Ólafur Eysteinn Sigurjónsson (Ólafur E Sigurjónsson, Olafur E Sigurjonsson, Ólafur E Sigurjonsson, Olafur Sigurjonsson, Olafur Eysteinn Sigurjonsson)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Transfusion

Pharmaceutics

Metabolites

Bioengineering (Basel, Switzerland)

Haskolinn i Reykjavik

University of Oslo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Haskolinn i Reykjavik

Iceland

Professor :: School of Science and Engineering

Landspítali University Hospital Feb 01 2006

Iceland

Director of RnD and Laboratory director of the hematopoietic stem cell program :: The Blood bank

Education History

University of Oslo Mar 01 2002 - Mar 01 2006

Norway

PHD :: Department of Medicine

University of Iceland Sep 01 1999 - Sep 01 2001

Iceland

MSC :: Department of Medicine

University of Iceland Sep 01 1995 - Jun 17 1998

Iceland

BSC :: Department of biology

Publications

Freyr Jóhannsson, Bernhard O Palsson, Steinn Guðmundsson, Ólafur Eysteinn Sigurjónsson, Óttar Rolfsson
Temperature Dependence of Platelet Metabolism. Metabolites 14 (2) (2024)
Freyr Jóhannsson, Bernhard O Palsson, Steinn Guðmundsson, Ólafur Eysteinn Sigurjónsson, Óttar Rolfsson
Temperature Dependence of Platelet Metabolism. Metabolites 14 (2) (2024)
Freyr Jóhannsson, Bernhard O Palsson, Steinn Guðmundsson, Ólafur Eysteinn Sigurjónsson, Óttar Rolfsson
Temperature Dependence of Platelet Metabolism. Metabolites 14 (2) (2024)
Torunn Oveland Apelseth, Barry Doyle, Ryan Evans, Chloe George, Catherine Humbrecht, Thomas Klei, Tome Najdovski, Ólafur Eysteinn Sigurjónsson, Michael Wiltshire, Dirk de Korte
Current transfusion practice and need for new blood products to ensure blood supply for patients with major hemorrhage in Europe. Transfusion (2023)
Gabriele Boretti, Emanuele Giordano, Mariana Ionita, George Mihail Vlasceanu, Ólafur Eysteinn Sigurjónsson, Paolo Gargiulo, Joseph Lovecchio
Human Bone-Marrow-Derived Stem-Cell-Seeded 3D Chitosan-Gelatin-Genipin Scaffolds Show Enhanced Extracellular Matrix Mineralization When Cultured under a Perfusion Flow in Osteogenic Medium. Materials (Basel, Switzerland) 16 (17) (2023)
Helena Hamzehpour, Ástrós Óskarsdóttir, Helgi Jónsson, Fjóla Jónsdóttir, Ólafur Eysteinn Sigurjónsson, Bergthora S Snorradottir
Transdermal Drug Delivery of Tazarotene: Determining Tazarotene's Potential in Local Transdermal Therapy. Pharmaceutics 16 (1) (2023)
Helena Hamzehpour, Ástrós Óskarsdóttir, Helgi Jónsson, Fjóla Jónsdóttir, Ólafur Eysteinn Sigurjónsson, Bergthora S Snorradottir
Transdermal Drug Delivery of Tazarotene: Determining Tazarotene's Potential in Local Transdermal Therapy. Pharmaceutics 16 (1) (2023)
Helena Hamzehpour, Ástrós Óskarsdóttir, Helgi Jónsson, Fjóla Jónsdóttir, Ólafur Eysteinn Sigurjónsson, Bergthora S Snorradottir
Transdermal Drug Delivery of Tazarotene: Determining Tazarotene's Potential in Local Transdermal Therapy. Pharmaceutics 16 (1) (2023)
Niels Arni Arnason, Freyr Johannsson, Ragna Landrö, Björn Hardarsson, Sveinn Gudmundsson, Aina-Mari Lian, Janne Elin Reseland, Ottar Rolfsson, Ólafur Eysteinn Sigurjónsson
Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination. Pathogens (Basel, Switzerland) 11 (3) (2022)
Thora Bjorg Sigmarsdottir, Sarah McGarrity, Adrian Lopez Garcia de Lomana, Aristotelis Kotronoulas, Snaevar Sigurdsson, Bernhard O Palsson, Ottar Rolfsson, Ólafur Eysteinn Sigurjónsson
Metabolic and Transcriptional Changes across Osteogenic Differentiation of Mesenchymal Stromal Cells. Bioengineering (Basel, Switzerland) 8 (12) (2021)
Catalin Constantinescu, Sergiu Pasca, Alina-Andreea Zimta, Tiberiu Tat, Ioana Rus, Patric Teodorescu, Sabina Iluta, Alina Daniela Tanase, Anca Colita, Ólafur Eysteinn Sigurjónsson, Hermann Einsele, Ciprian Ionuț Tomuleasa
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies. Journal of clinical medicine 9 (9) (2020)
Alina-Andreea Zimta, Ólafur Eysteinn Sigurjónsson, Diana Gulei, Ciprian Ionuț Tomuleasa
The Malignant Role of Exosomes as Nanocarriers of Rare RNA Species. International journal of molecular sciences 21 (16) (2020)
Marta Mikaelsdottir, Brynjar Vidarsson, Gudmundur Runarsson, Una Bjarnadottir, Pall T Onundarson, Ólafur Eysteinn Sigurjónsson, Anna Margret Halldorsdottir
A comparison of platelet quality between platelets from healthy donors and hereditary hemochromatosis donors over seven-day storage. Transfusion 61 (1) (2020)
Christian Christensen, Sandra Mjoll Jonsdottir-Buch, Ólafur Eysteinn Sigurjónsson
Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study. PloS one 15 (4) (2020)
Niels Arni Arnason, Freyr Johannson, Ragna Landrö, Björn Hardarsson, Johannes Irsch, Sveinn Gudmundsson, Óttar Rolfsson, Ólafur Eysteinn Sigurjónsson
Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions. Transfusion 59 (12) (2019)
Freyr Jóhannsson, Níels Á Árnason, Ragna Landrö, Sveinn Guðmundsson, Ólafur Eysteinn Sigurjónsson, Óttar Rolfsson
Metabolomics study of platelet concentrates photochemically treated with amotosalen and UVA light for pathogen inactivation. Transfusion 60 (2) (2019)

Ólafur Eysteinn Sigurjónsson.css-eqlu8i{font-size:small;padding-left:4px;} (Ólafur E Sigurjónsson, Olafur E Sigurjonsson, Ólafur E Sigurjonsson, Olafur Sigurjonsson, Olafur Eysteinn Sigurjonsson)

Publication Activity (10 Years)

Top Topics

Top Venues

Ólafur Eysteinn Sigurjónsson (Ólafur E Sigurjónsson, Olafur E Sigurjonsson, Ólafur E Sigurjonsson, Olafur Sigurjonsson, Olafur Eysteinn Sigurjonsson)